Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Prestige Consumer Healthcare, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.13% and Operating profit at 3.08% over the last 5 years
2
Flat results in Jun 25
- NET SALES(Q) Lowest at USD 249.53 MM
- OPERATING PROFIT(Q) Lowest at USD 79.42 MM
- NET PROFIT(Q) Lowest at USD 47.47 MM
3
With ROCE of 12.76%, it has a fair valuation with a 1.99 Enterprise value to Capital Employed
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -27.16%, its profits have risen by 6.6% ; the PEG ratio of the company is 3
4
Below par performance in long term as well as near term
- Along with generating -27.16% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Prestige Consumer Healthcare, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Prestige Consumer Healthcare, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Prestige Consumer Healthcare, Inc.
-25.63%
-0.26
28.69%
S&P 500
17.78%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
2.90%
EBIT Growth (5y)
2.19%
EBIT to Interest (avg)
5.29
Debt to EBITDA (avg)
3.40
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.40
Tax Ratio
24.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.87%
ROE (avg)
14.20%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.79
EV to EBIT
11.98
EV to EBITDA
11.04
EV to Capital Employed
1.54
EV to Sales
3.73
PEG Ratio
1.71
Dividend Yield
NA
ROCE (Latest)
12.84%
ROE (Latest)
11.94%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Movement
5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 276.64 MM
RAW MATERIAL COST(Y)
Fallen by 0.13% (YoY
CASH AND EQV(HY)
Highest at USD 181.48 MM
-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.2 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.17 times
OPERATING PROFIT MARGIN(Q)
Lowest at 31.78 %
Here's what is working for Prestige Consumer Healthcare, Inc.
Operating Cash Flow
Highest at USD 276.64 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 181.48 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by 0.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Prestige Consumer Healthcare, Inc.
Operating Profit Margin
Lowest at 31.78 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 3.2 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 6.17 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






